BD1.AX - BARD1 Life Sciences Limited

ASX - ASX Delayed price. Currency in AUD
Currency in AUD

Valuation measures

Market cap (intra-day) 530.08M
Enterprise value 326.12M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)113.65
Price/book (mrq)10.00
Enterprise value/revenue 398.68
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (3Y monthly) -7.82
52-week change 3113.55%
S&P500 52-week change 3-0.33%
52-week high 30.0728
52-week low 30.0097
50-day moving average 30.0296
200-day moving average 30.0220

Share statistics

Avg vol (3-month) 38.87M
Avg vol (10-day) 36.08M
Shares outstanding 51.24B
Float 635.67M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor (new per old) 210/1
Last split date 311 Sep. 2008

Financial highlights

Fiscal year

Fiscal year ends 30 Jun. 2018
Most-recent quarter (mrq)31 Dec. 2018


Profit margin 0.00%
Operating margin (ttm)-718.89%

Management effectiveness

Return on assets (ttm)-47.68%
Return on equity (ttm)-89.92%

Income statement

Revenue (ttm)264.68k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)-4.60%
Gross profit (ttm)-685.7k
Net income avi to common (ttm)-1.92M
Diluted EPS (ttm)-0.0030
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.71M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.14
Book value per share (mrq)0.00

Cash flow statement

Operating cash flow (ttm)-1.82M
Levered free cash flow (ttm)-1.12M